1. Home
  2. DBVT vs TITN Comparison

DBVT vs TITN Comparison

Compare DBVT & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • TITN
  • Stock Information
  • Founded
  • DBVT 2002
  • TITN 1980
  • Country
  • DBVT France
  • TITN United States
  • Employees
  • DBVT N/A
  • TITN N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • TITN Other Specialty Stores
  • Sector
  • DBVT Health Care
  • TITN Consumer Discretionary
  • Exchange
  • DBVT Nasdaq
  • TITN Nasdaq
  • Market Cap
  • DBVT 464.0M
  • TITN 387.3M
  • IPO Year
  • DBVT N/A
  • TITN 2007
  • Fundamental
  • Price
  • DBVT $15.55
  • TITN $16.52
  • Analyst Decision
  • DBVT Buy
  • TITN Buy
  • Analyst Count
  • DBVT 4
  • TITN 4
  • Target Price
  • DBVT $14.81
  • TITN $22.25
  • AVG Volume (30 Days)
  • DBVT 203.8K
  • TITN 220.7K
  • Earning Date
  • DBVT 10-28-2025
  • TITN 11-25-2025
  • Dividend Yield
  • DBVT N/A
  • TITN N/A
  • EPS Growth
  • DBVT N/A
  • TITN N/A
  • EPS
  • DBVT N/A
  • TITN N/A
  • Revenue
  • DBVT $3,800,000.00
  • TITN $2,580,509,000.00
  • Revenue This Year
  • DBVT $1,743.46
  • TITN N/A
  • Revenue Next Year
  • DBVT $1,044.34
  • TITN N/A
  • P/E Ratio
  • DBVT N/A
  • TITN N/A
  • Revenue Growth
  • DBVT N/A
  • TITN N/A
  • 52 Week Low
  • DBVT $2.21
  • TITN $12.50
  • 52 Week High
  • DBVT $18.00
  • TITN $23.41
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 60.41
  • TITN 50.55
  • Support Level
  • DBVT $14.85
  • TITN $15.30
  • Resistance Level
  • DBVT $16.95
  • TITN $15.94
  • Average True Range (ATR)
  • DBVT 1.14
  • TITN 0.52
  • MACD
  • DBVT -0.18
  • TITN 0.23
  • Stochastic Oscillator
  • DBVT 28.24
  • TITN 83.79

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

Share on Social Networks: